Skip to content
Full Committee Hearing

The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay, Part II

Date:
Time: 10:00am
Location: 430 Dirksen Senate Office Building

Witnesses

  • Lori M. Reilly

    Executive Vice President
    Policy, Research & Membership, Pharmaceutical Research and Manufacturers of America
    Washington, D.C.
  • Chester “Chip” Davis, Jr.

    President and Chief Executive Officer
    Association for Accessible Medicines
    Washington, D.C.
  • Elizabeth A. Gallenagh

    Senior Vice President Government Affairs and General Counsel
    Healthcare Distribution Alliance
    Arlington, VA
  • Mark Merritt

    President and Chief Executive Officer
    Pharmaceutical Care Management Association
    Washington, D.C.
  • Thomas E. Menighan, BSPharm, MBA, ScD(Hon.), FAPhA

    Executive Director and Chief Executive Officer
    American Pharmacists Association
    Washington, D.C.

Related Issues

Related Photos